Total Payments
$3,138
2024 Payments
$906.25
Companies
22
Transactions
161
Medicare Patients
3,382
Medicare Billing
$250,088
Payment Breakdown by Category
Food & Beverage$3,138 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,138 | 161 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,032 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $369.00 | 24 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $296.28 | 20 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $216.32 | 6 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $173.79 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $153.53 | 7 | $0 (2024) |
| Celgene Corporation | $138.62 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $138.31 | 2 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $116.19 | 6 | $0 (2024) |
| VIVUS LLC | $80.29 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $906.25 | 37 | AIMMUNE THERAPEUTICS, INC. ($216.32) |
| 2023 | $640.22 | 31 | ABBVIE INC. ($210.48) |
| 2022 | $707.70 | 33 | ABBVIE INC. ($355.47) |
| 2021 | $884.30 | 60 | AbbVie Inc. ($286.07) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA, SKYRIZI | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Oncology | ||||||
| 04/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/08/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $83.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Immunology | ||||||
| 01/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Neuroscience | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/08/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
| 10/23/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: GI | ||||||
| 10/18/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/05/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $113.33 | General |
| Category: Immunology | ||||||
| 09/26/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/08/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 834 | 1,040 | $135,192 | $62,160 |
| 2022 | 4 | 839 | 1,025 | $140,457 | $63,417 |
| 2021 | 4 | 898 | 1,123 | $149,954 | $71,663 |
| 2020 | 6 | 811 | 963 | $129,762 | $52,849 |
Total Patients
3,382
Total Services
4,151
Medicare Billing
$250,088
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 490 | 674 | $75,488 | $37,169 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 143 | $23,452 | $11,625 | 49.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 186 | 186 | $30,504 | $11,172 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,735 | $1,567 | 41.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $748.00 | $338.22 | 45.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,265 | $289.20 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 437 | 579 | $64,848 | $30,017 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 245 | 245 | $40,180 | $16,449 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 172 | $28,208 | $14,181 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $7,221 | $2,769 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 501 | 694 | $77,728 | $38,755 | 49.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 261 | 261 | $42,804 | $18,155 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 146 | $23,944 | $12,220 | 51.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $5,478 | $2,533 | 46.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 436 | 558 | $62,496 | $25,324 | 40.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 199 | 199 | $32,636 | $13,309 | 40.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 120 | 150 | $24,600 | $10,194 | 41.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $7,719 | $3,401 | 44.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 13 | 13 | $1,495 | $466.59 | 31.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $816.00 | $154.18 | 18.9% |
About Robyn Carlisle, ARNP-C
Robyn Carlisle, ARNP-C is a Nurse Practitioner healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1407026719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robyn Carlisle, ARNP-C has received a total of $3,138 in payments from pharmaceutical and medical device companies, with $906.25 received in 2024. These payments were reported across 161 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,138).
As a Medicare-enrolled provider, Carlisle has provided services to 3,382 Medicare beneficiaries, totaling 4,151 services with total Medicare billing of $250,088. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Summerfield, FL
- Active Since 03/04/2008
- Last Updated 07/07/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1407026719
Products in Payments
- ZENPEP (Drug) $468.28
- LINZESS (Drug) $432.47
- XIFAXAN (Drug) $334.60
- ZEPOSIA (Drug) $191.56
- VOQUEZNA (Drug) $173.79
- MAVYRET (Drug) $148.46
- CREON (Drug) $127.24
- ENTYVIO (Biological) $126.69
- Linzess (Drug) $116.19
- RINVOQ (Biological) $113.92
- STELARA (Biological) $113.33
- HUMIRA (Biological) $107.02
- DUPIXENT (Biological) $104.60
- VIBERZI (Drug) $102.73
- QSYMIA (Drug) $55.72
- OCALIVA (Drug) $50.40
- DIFICID (Drug) $44.91
- VOWST (Biological) $44.32
- CYLTEZO (Drug) $29.88
- OMVOH (Drug) $27.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Summerfield
Ashley Davis, Fnp, FNP
Nurse Practitioner — Payments: $2,308
Nurse Practitioner $2,308
Ms. Melinda Rogers, Arnp, ARNP
Nurse Practitioner — Payments: $1,319
Nurse Practitioner $1,319
Kristen Teel, Pa-C, PA-C
Nurse Practitioner — Payments: $818.86
Nurse Practitioner $818.86
Amy Ester, Fnp-C, FNP-C
Nurse Practitioner — Payments: $97.85
Nurse Practitioner $97.85
Lauren Smith, Dnp, DNP
Nurse Practitioner
Nurse Practitioner